Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Omega Healthcare Investors Stock Performance
Shares of NYSE:OHI opened at $39.98 on Friday. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. The company has a market capitalization of $10.31 billion, a price-to-earnings ratio of 36.02, a price-to-earnings-growth ratio of 1.30 and a beta of 1.00. The firm has a 50 day moving average of $39.04 and a 200 day moving average of $34.55. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $41.53.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). The company had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. Omega Healthcare Investors’s revenue for the quarter was up 17.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.74 EPS. On average, sell-side analysts predict that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.
Omega Healthcare Investors Dividend Announcement
Institutional Investors Weigh In On Omega Healthcare Investors
Several institutional investors have recently added to or reduced their stakes in the business. Park Avenue Securities LLC increased its stake in Omega Healthcare Investors by 59.3% during the 3rd quarter. Park Avenue Securities LLC now owns 17,088 shares of the real estate investment trust’s stock valued at $695,000 after purchasing an additional 6,360 shares in the last quarter. SG Americas Securities LLC purchased a new position in shares of Omega Healthcare Investors in the third quarter worth about $1,288,000. NCP Inc. lifted its holdings in shares of Omega Healthcare Investors by 10.3% during the second quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock worth $113,000 after purchasing an additional 310 shares during the period. B. Riley Wealth Advisors Inc. boosted its position in Omega Healthcare Investors by 297.4% in the second quarter. B. Riley Wealth Advisors Inc. now owns 37,516 shares of the real estate investment trust’s stock valued at $1,285,000 after buying an additional 28,075 shares during the last quarter. Finally, Regal Investment Advisors LLC increased its holdings in Omega Healthcare Investors by 10.6% in the 2nd quarter. Regal Investment Advisors LLC now owns 7,037 shares of the real estate investment trust’s stock worth $241,000 after buying an additional 677 shares during the period. Institutional investors and hedge funds own 65.25% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on the company. Truist Financial lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday. Scotiabank raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Finally, Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and lifted their price target for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $36.00.
Check Out Our Latest Analysis on Omega Healthcare Investors
Omega Healthcare Investors Company Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Featured Stories
- Five stocks we like better than Omega Healthcare Investors
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- When Is the Best Time to Invest in Mutual Funds?
- Where to Find Earnings Call Transcripts
- Is NVIDIA Stock in a Correction or Consolidation?
- Conference Calls and Individual Investors
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.